Results 31 to 40 of about 7,815 (117)

Nephrogenic systemic fibrosis presenting as myopathy: A case report with histopathologic correlation

open access: yes, 2010
Nephrogenic systemic fibrosis is primarily a skin disorder associated with renal insufficiency and exposure to gadolinium-containing (GAD+) contrast. We present the case of a 64-year-old man who was exposed to gadolinium while in acute renal failure, and
Woltjer, Randy   +5 more
core   +1 more source

The Detection and Characterization of Nanoparticulate Heavy Metals in Epithelial Tissues in Patients with Nephrogenic Fibrosing Dermopathy

open access: yes, 2007
Certain diseases have been associated with the administration of heavy elements as contrast agents to patients undergoing medical imaging procedures. Recently, the presence of gadolinium (Gd) administered as a paramagnetic contrast agent for MRI contrast
Reed Ayers   +3 more
core   +1 more source

Differential Diagnosis of Thyroid Dermopathy and Acropachy with Arthritis

open access: yes, 2021
Thyroid acropachy is a rare manifestation of autoimmune thyroid disease with characteristic imaging findings. Clinically, it is almost always associated with thyroid ophthalmopathy and dermopathy.
Pelin Gümüş Ok, Nurdan Yılmaz
core   +1 more source

Dialysis-associated systemic fibrosis (nephrogenic fibrosing dermopathy): study of inflammatory cells and transforming growth factor beta1 expression in affected skin

open access: yes, 2004
OBJECTIVE: Nephrogenic fibrosing dermopathy (NFD) is a newly recognized cutaneous fibrotic disorder occurring in individuals with end-stage renal disease (ESRD).
Latinis, Kevin   +7 more
core   +1 more source

Nephrogenic systemic fibrosis: a systemic fibrosing disease resulting from gadolinium exposure

open access: yes, 2015
Nephrogenic systemic fibrosis (NSF) is an iatrogenic fibrosing disorder that primarily affects individuals with chronic kidney disease (CKD) following exposure to gadolinium-based contrast agents (GBCAs) during imaging procedures. NSF is characterised by
Bernstein, Elana J.   +2 more
core   +1 more source

Nephrogenic fibrosing dermopathy or nephrogenic systemic fibrosis? What do we know and what do we have to learn?

open access: yes, 2009
Nephrogenic systemic fibrosis (NSF) was first recognized as a unique entity in 1997 and subsequently defined in the literature in 2000 as a novel fibrosing disorder occurring in the setting of renal disease.
Ortega, L M, Contreras, G, Lenz, O
core   +1 more source

Nephrogenic systemic fibrosis: clinicopathological definition and workup recommendations

open access: yes, 2015
BACKGROUND: The condition that came to be known as nephrogenic systemic fibrosis (NSF) was first reported in 2000 and, in 2001, was termed "nephrogenic fibrosing dermopathy." Since then, NSF has been the subject of a wide-ranging multidisciplinary ...
Elston, Dirk M.   +5 more
core   +1 more source

Multiple well-demarcated skin-colored papules and nodules. [PDF]

open access: yesJAAD Case Rep, 2022
Santa Lucia G   +4 more
europepmc   +1 more source

Nephrogenic systemic fibrosis: an epidemic of gadolinium toxicity

open access: yes, 2009
Nephrogenic systemic fibrosis is a devastating systemic fibrosing disorder that afflicts patients with renal dysfunction. Growing evidence supports the hypothesis that gadolinium-containing contrast agents (GCCAs) trigger the development of nephrogenic ...
Kay, Jonathan, Todd, Derrick James
core   +1 more source

The Debate Between Gadolinium Versus Erythropoietin in a Renal Transplant Patient With Nephrogenic Systemic Fibrosis

open access: yes, 2013
Nephrogenic systemic fibrosis (NSF), previously known as nephrogenic fibrosing dermopathy, is a debilitating skin condition that causes fibrotic changes in the setting of renal failure.
Safai, Bijan   +3 more
core   +1 more source

Home - About - Disclaimer - Privacy